Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum concentration study of ropivacaine after hip fracture surgery
2009-013396-22Phase 4Terminated
- Sponsor
- University Hospital Odense
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in intertrochanteric fracture, sponsored by University Hospital Odense. Primary endpoint: Serum level of Naropin (ropivacaine). Started Jul 2009; status: terminated.
02
Drugs
ropivacaine
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on 2009-013396-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013396-22.